Save the date for our virtual Research Day! We will share new data highlighting our differentiated RNA medicines platform, including our best-in-class chemistry, hepatic and extra-hepatic capabilities, and RNAi, RNA editing, and bifunctional modalities. Arun J. Sanyal, MD, FAASLD, a leading hepatologist, will join to offer perspectives on PNPLA3 liver disease and the opportunity for an RNA editing approach. Register here: wave-life-sciences-research-…

Are MASLD and bone-health connected? 🦴 Check out our translational study from @VCU_Liver, published in @CommsBio @NaturePortfolio, linking large-scale EHR data with mechanistic work in mice 🐁 MASLD is associated with ⬆️ fracture risk in humans Animal models point to impaired new bone formation and altered liver-bone signalling as potential mechanisms ⚙️ Kudos to @VCU MD/PhD student Galen for leading this, and Prof @ArunJSanyalVCU for guidance 🙏 🔗 nature.com/articles/s42003-0… @VCUHealth @VCUENGR @CoulterBME @UVABME @ucdavisvetmed @AASLDtweets @EASLedu

I am joining The VITAL Initiative's pre-EASD roundtable to talk about midlife and type 2 diabetes. The years when the picture changes, and the conversation in clinic has to change with it. 21 September, and free to join for HCPs. radc.life/8GVKnuO6 #VITALmetabolic

As American Liver Foundation celebrates 50 years of advancing liver health, we are proud to honor one of the field's most influential pioneers. Dr. Arun J. Sanyal has helped transform the global understanding and treatment of MASLD and MASH, driving groundbreaking research that has improved the lives of countless patients and families around the world. As Director of the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at Virginia Commonwealth University, his leadership continues to shape the future of liver disease prevention, diagnosis, and care. In this Golden Anniversary year, we are honored to present Arun J. Sanyal, MD with the 2026 National Legacy Gala Leadership Award on October 28 in New York City. Join us as we celebrate 50 years of impact and recognize the visionary leaders helping create a future without liver disease. alf.social/gala26 @VCU_Liver #ALF50 #NationalLegacyGala

Hearing @ArunJSanyalVCU talk about the burden of guilty & lack of joy our patients deal with & hamper their health was inspiring. Having an intentional known investigator change perspective & talk about how much his learning continues was aspirational. I always feel like I am the only one that still has so much to learn! @AASLDtweets @alehlatam

#CGH4ALL @AGA_CGH 📣 🚫🧫 Could serial liver biopsies become a thing of the past in MASH? 🔄 A paradigm shift in MASH treatment monitoring!🫀✨ 🧫➡️📊 From histology toward NITs, with LSM emerging as the key non-invasive measure 🎯 ≥30% reduction in LSM= a clinically meaningful treatment response 📉🔬 #MASH #NonInvasiveTests #LiverStiffness #Hepatology #AGACGH Learn more at 🔗 doi.org/10.1016/j.cgh.2025.1…. Reported by @talal_khurshid @NoureddinMD @aldomontanoloza @RichSterlingMD @ajay_duseja @SanjayaSatapath @AlinaAllenMD @juanpabloarab @norahterrault @ArunJSanyalVCU @BrettEFortuneMD @Dr_Vijay_Shah @DougSimonetto @AlinaAllenMD @AlkhouriNaim @mqkMD @scottisaacsmd @serperm @nadimmahmud @NoureddinMD @aldomontanoloza @RichSterlingMD @ajay_duseja @SanjayaSatapath @AlinaAllenMD @juanpabloarab @norahterrault @ArunJSanyalVCU @BrettEFortuneMD @Dr_Vijay_Shah @DougSimonetto @AlinaAllenMD @AlkhouriNaim @mqkMD @scottisaacsmd @serperm @nadimmahmud

🌟 Welcome Dr. Jawaid Shaw to the Mayo Clinic Transplant Hepatology Fellowship! 🌟 Dr. Shaw chose Mayo Clinic to advance his career and is looking forward to strengthening his clinical expertise, expanding his research focus, and shaping his future path in hepatology. His long-term goal is a career in academic medicine. Fun fact: He describes himself as a lighthearted and humorous person who enjoys bringing positivity to those around him! #MayoGI #TransplantHepatology #HepatologyFellowship #MayoClinic #WelcomeToMayo